Much is still not known about the end-state of core materials in each unit that was operating on March 11, 2011 at the Fukushima Daiichi Nuclear Power Station (Daiichi). Information obtained from Daiichi is required to inform Decontamination and Decommissioning (D&D) activities, improving the ability of the Tokyo Electric Power Company Holdings, Incorporated (TEPCO Holdings) to characterize potential hazards and to ensure the safety of workers involved with cleanup activities. This document, which has been updated to include Fiscal Year 2019 (FY2019) information, summarizes results from a U.S. effort to review Daiichi information and extract insights to enhance the safety of existing and future nuclear power plant designs. This U.S. effort, which was initiated in 2014 by the Department of Energy Office of Nuclear Energy (DOE-NE), is completed by a group of experts in reactor safety and plant operations that identify examination needs and evaluate recent Daiichi examination data to address these needs. Each year, annual reports are issued that document significant safety insights being obtained in areas of special emphasis. For FY2019, the areas emphasized by the expert panel include component performance, radionuclide surveys and sampling, debris end-state location, combustible gas effects, and plant operations and maintenance. In addition to reducing uncertainties related to severe accident modeling progression, these insights have and continue to be used to update guidance for severe accident prevention, mitigation, and emergency planning. Reduced uncertainties in modeling the events at Daiichi improve the realism of reactor safety evaluations that inform future D&D activities. In addition, the process established by this U.S. effort provides an example that Japan may wish to implement in future international efforts to support D&D.
This is the third part of the three part paper describing the accidents at the Fukushima Daiichi nuclear power station as analyzed in the Phase 2 of the OECD/NEA project "Benchmark Study of the Accident at the Fukushima Daiichi Nuclear Power Plant" (BSAF). In this paper, we describe the accident progression in unit 3. Units 1 and 2 are discussed in parts 1 and 2 of this series of papers.In the BSAF project, eight organizations from five countries (CRIEPI, IAE, JAEA and NRA, Japan; IRSN France; PSI, Switzerland; SNL, USA; VTT, Finland) analyzed severe accident scenarios for Unit 3 at the Fukushima Daiichi site using different severe accident codes (ASTEC, MAAP, MELCOR, SAMPSON, THALES). The present paper for Unit 3 describes the findings of the comparison of the participants' results against each other and against plant data, the evaluation of the accident progression and the final status inside the reactors. Special focus is on the status of the reactor pressure vessel, melt release and fission product release and transport. Unit 3 specific aspects, e.g., the complicated accident progression following repeated containment venting actuations and attempts at coolant injection at the time of the major core degradation, are highlighted and points of consensus as well as remaining uncertainties and data needs will be summarized. Fission product transport is analyzed, and the calculation results are compared with dose rate measurements in the containment. The release of I-131 and Cs-137 to the environment is compared with analysis conducted using WSPEEDI code.
† The term "safety in design" is most completely described in a DOE standard for nuclear facility design, DOE-STD-1189, "Safety in Design" which describes a process for integrating safety analysis into the design process for nuclear facilities.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.